MedTrace Logo

Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section

NCT02101567 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-04-10

No results posted yet for this study

Summary

The investigators compare the effectiveness and adverse effects of I.V carbetocin versus oxytocin \& ergometrine I.V for prevention of postpartum haemorrhage following cesarean section.

Conditions

Interventions

DRUG

Pabal 100 mcg iv infusion over 1 minute given after delivery of fetal head

In the first group of patients, carbitocin 100 mcg will be given iv infusion over one minute after delivery of the head in cesarean section.

DRUG

Oxytocin 5 IU iv infusion and Methtergine 0.2 mg iv

In the second group of patients oxytocin 5 IU will be given iv infusion and Methergine 0.2 mg iv

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Nesreen A Shehata, MD · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02101567 on ClinicalTrials.gov